Product Information
OXYBUTYNIN CL ER 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0875 per EA under NDC 64980020901. Its NADAC has been published 495 times since Jan 4, 2017.
The High Outlier badge above means this manufacturer's average price in the Oxybutynin Chloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980020901
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206121On Market Since
9/27/2016
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 5 MG TABLET has been published 495 times since Jan 4, 2017, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0875 per EA |
|---|---|
| All-time high | $0.7230 (Jan 11, 2017) |
| All-time low | $0.0765 (Nov 20, 2024) |
| 52-week high | $0.0990 |
| 52-week low | $0.0875 |
| Median price | $0.1699 |
| Average price | $0.2395 |
| Largest weekly change | +35.7% (Jun 19, 2024) |
| Weeks tracked | 495 |
| Tracking since | Jan 4, 2017 |
Generic Alternatives
The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0875 per EA (NDC 64980020901), effective Jun 24, 2026.
How has the price of OXYBUTYNIN CL ER 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 5 MG TABLET has declined 87.9%. It has been tracked across 495 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 5 MG TABLET?
Since Jan 4, 2017, the NADAC for OXYBUTYNIN CL ER 5 MG TABLET has ranged from a low of $0.0765 (Nov 20, 2024) to a high of $0.7230 (Jan 11, 2017), with a median of $0.1699 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 5 MG TABLET?
Yes. 14 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OXYBUTYNIN 5 MG TABLET, is $0.0473 per EA — about 46% below OXYBUTYNIN CL ER 5 MG TABLET.
Who manufactures OXYBUTYNIN CL ER 5 MG TABLET?
OXYBUTYNIN CL ER 5 MG TABLET (NDC 64980020901) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification